| Trial registration number
|
NCT04878042 |
Full text link
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04878042
|
First author
Last imported at : Nov. 28, 2022, 8 a.m.
Source : ClinicalTrials.gov
|
Antonio I Lazzarino
|
Contact
Last imported at : Nov. 28, 2022, 8 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-05-07
|
Recruitment status
Last imported at : Nov. 28, 2022, 8 a.m.
Source : ClinicalTrials.gov
|
Withdrawn
|
Study design
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- recent positive sars-cov-2 pcer swab test
|
Exclusion criteria
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
- severe covid19 disease
|
Number of arms
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
EPISTATA
|
Inclusion age min
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
90
|
Countries
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Italy
|
Type of patients
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Nov. 28, 2022, 8 a.m.
Source : ClinicalTrials.gov
|
0
|
primary outcome
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
The negativisation rate of a positive SARS-CoV-2 (COVID-19) PCR nose swab test
|
Notes
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : May 9, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 606, "treatment_name": "Hydrogen peroxide", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|